283 related articles for article (PubMed ID: 18074402)
1. Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes.
Allamand V; Bidou L; Arakawa M; Floquet C; Shiozuka M; Paturneau-Jouas M; Gartioux C; Butler-Browne GS; Mouly V; Rousset JP; Matsuda R; Ikeda D; Guicheney P
J Gene Med; 2008 Feb; 10(2):217-24. PubMed ID: 18074402
[TBL] [Abstract][Full Text] [Related]
2. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
[TBL] [Abstract][Full Text] [Related]
3. Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies.
Hadj Salem I; Kamoun F; Louhichi N; Rouis S; Mziou M; Fendri-Kriaa N; Makni-Ayadi F; Triki C; Fakhfakh F
Biosci Rep; 2011 Apr; 31(2):125-35. PubMed ID: 20477750
[TBL] [Abstract][Full Text] [Related]
4. Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment.
Bidou L; Hatin I; Perez N; Allamand V; Panthier JJ; Rousset JP
Gene Ther; 2004 Apr; 11(7):619-27. PubMed ID: 14973546
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA.
Sako Y; Usuki F; Suga H
Nucleic Acids Symp Ser (Oxf); 2006; (50):239-40. PubMed ID: 17150906
[TBL] [Abstract][Full Text] [Related]
6. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease.
Usuki F; Yamashita A; Higuchi I; Ohnishi T; Shiraishi T; Osame M; Ohno S
Ann Neurol; 2004 May; 55(5):740-4. PubMed ID: 15122717
[TBL] [Abstract][Full Text] [Related]
8. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
[TBL] [Abstract][Full Text] [Related]
9. LAMA2 mRNA processing alterations generate a complete deficiency of laminin-alpha2 protein and a severe congenital muscular dystrophy.
Siala O; Louhichi N; Triki C; Morinière M; Fakhfakh F; Baklouti F
Neuromuscul Disord; 2008 Feb; 18(2):137-45. PubMed ID: 18053718
[TBL] [Abstract][Full Text] [Related]
10. [Specific inhibition of nonsense-mediated mRNA decay has the potential to rescue the phenotype of muscular dystrophy].
Usuki F
Rinsho Shinkeigaku; 2006 Nov; 46(11):939-41. PubMed ID: 17432226
[TBL] [Abstract][Full Text] [Related]
11. Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Mutations in brief no. 159. Online.
Mendell JT; Panicker SG; Tsao CY; Feng B; Sahenk Z; Marzluf GA; Mendell JR
Hum Mutat; 1998; 12(2):135. PubMed ID: 10694916
[TBL] [Abstract][Full Text] [Related]
12. Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders.
Shiozuka M; Wagatsuma A; Kawamoto T; Sasaki H; Shimada K; Takahashi Y; Nonomura Y; Matsuda R
J Biochem; 2010 Apr; 147(4):463-70. PubMed ID: 19910311
[TBL] [Abstract][Full Text] [Related]
13. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).
Allamand V; Guicheney P
Eur J Hum Genet; 2002 Feb; 10(2):91-4. PubMed ID: 11938437
[TBL] [Abstract][Full Text] [Related]
14. Introducing sense into nonsense in treatments of human genetic diseases.
Linde L; Kerem B
Trends Genet; 2008 Nov; 24(11):552-63. PubMed ID: 18937996
[TBL] [Abstract][Full Text] [Related]
15. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges.
Kuzmiak HA; Maquat LE
Trends Mol Med; 2006 Jul; 12(7):306-16. PubMed ID: 16782405
[TBL] [Abstract][Full Text] [Related]
16. [Nonsense-mediated mRNA decay (NMD)--on guard of mRNA quality].
Dzikiewicz A; Szweykowska-Kulińska Z
Postepy Biochem; 2006; 52(4):390-8. PubMed ID: 17536508
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nonsense-mediated mRNA decay in mutant alleles identified in Spanish Gaucher disease patients.
Montfort M; Chabás A; Vilageliu L; Grinberg D
Blood Cells Mol Dis; 2006; 36(1):46-52. PubMed ID: 16326120
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.
Malik V; Rodino-Klapac LR; Viollet L; Wall C; King W; Al-Dahhak R; Lewis S; Shilling CJ; Kota J; Serrano-Munuera C; Hayes J; Mahan JD; Campbell KJ; Banwell B; Dasouki M; Watts V; Sivakumar K; Bien-Willner R; Flanigan KM; Sahenk Z; Barohn RJ; Walker CM; Mendell JR
Ann Neurol; 2010 Jun; 67(6):771-80. PubMed ID: 20517938
[TBL] [Abstract][Full Text] [Related]
19. LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regression.
Vigliano P; Dassi P; Di Blasi C; Mora M; Jarre L
Eur J Paediatr Neurol; 2009 Jan; 13(1):72-6. PubMed ID: 18406646
[TBL] [Abstract][Full Text] [Related]
20. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.
Kuschal C; DiGiovanna JJ; Khan SG; Gatti RA; Kraemer KH
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19483-8. PubMed ID: 24218596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
